Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity

Jingmei Lin, Noah C. Welker, Zijin Zhao, Yong Li, Jianjun Zhang , Sarah A. Reuss, Xinjun Zhang, Hwajeong Lee, Yunlong Liu, Mary P. Bronner

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The diagnosis of idiopathic inflammatory bowel disease can be challenging. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate protein synthesis through post-transcriptioal suppression. This study is to identify new miRNA markers in inflammatory bowel disease, and to examine whether miRNA biomarkers might assist in the diagnosis of inflammatory bowel disease. Illumina small RNA sequencing was performed on non-dysplastic fresh-frozen colonic mucosa samples of the distalmost colectomy tissue from 19 patients with inflammatory bowel disease (10 ulcerative colitis and 9 Crohn disease) and 18 patients with diverticular disease serving as controls. To determine differentially expressed miRNAs, the USeq software package identified 44 miRNAs with altered expression (fold change ≥2 and false discovery rate ≤0.10) compared with the controls. Among them, a panel of nine miRNAs was aberrantly expressed in both ulcerative colitis and Crohn disease. Validation assays performed using quantitative reverse transcription PCR (qRT-PCR) on additional frozen tissue from ulcerative colitis, Crohn disease, and control groups confirmed specific differential expression in inflammatory bowel disease for miR-31, miR-206, miR-424, and miR-146a (P<0.05). The expression of these four miRNAs was further evaluated on formalin-fixed, paraffin-embedded tissue of the distalmost colectomy mucosa from cohorts of diverticular disease controls (n=29), ulcerative colitis (n=36), Crohn disease (n=26), and the other diseases mimicking inflammatory bowel disease including infectious colitis (n=12) and chronic ischemic colitis (n=19), again confirming increased expression specific to inflammatory bowel disease (P<0.05). In summary, we demonstrate that miR-31, miR-206, miR-424, and miR-146a are novel specific biomarkers of inflammatory bowel disease. Furthermore, miR-31 is universally expressed in both ulcerative colitis and Crohn disease not only in fresh-frozen but also in formalin-fixed, paraffin-embedded tissues.

Original languageEnglish
Pages (from-to)602-608
Number of pages7
JournalModern Pathology
Volume27
Issue number4
DOIs
StatePublished - 2014

Fingerprint

MicroRNAs
Inflammatory Bowel Diseases
Biomarkers
Ulcerative Colitis
Crohn Disease
Colectomy
Paraffin
Formaldehyde
Mucous Membrane
Ischemic Colitis
RNA Sequence Analysis
Small Untranslated RNA
Colitis
Reverse Transcription
Software
Polymerase Chain Reaction
Control Groups

Keywords

  • colon
  • Crohn disease
  • idiopathic inflammatory bowel disease
  • microRNA
  • miR-31
  • next-generation sequencing
  • ulcerative colitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity. / Lin, Jingmei; Welker, Noah C.; Zhao, Zijin; Li, Yong; Zhang , Jianjun; Reuss, Sarah A.; Zhang, Xinjun; Lee, Hwajeong; Liu, Yunlong; Bronner, Mary P.

In: Modern Pathology, Vol. 27, No. 4, 2014, p. 602-608.

Research output: Contribution to journalArticle

Lin, Jingmei ; Welker, Noah C. ; Zhao, Zijin ; Li, Yong ; Zhang , Jianjun ; Reuss, Sarah A. ; Zhang, Xinjun ; Lee, Hwajeong ; Liu, Yunlong ; Bronner, Mary P. / Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity. In: Modern Pathology. 2014 ; Vol. 27, No. 4. pp. 602-608.
@article{65413b20941f45d49747b49f1627348d,
title = "Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity",
abstract = "The diagnosis of idiopathic inflammatory bowel disease can be challenging. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate protein synthesis through post-transcriptioal suppression. This study is to identify new miRNA markers in inflammatory bowel disease, and to examine whether miRNA biomarkers might assist in the diagnosis of inflammatory bowel disease. Illumina small RNA sequencing was performed on non-dysplastic fresh-frozen colonic mucosa samples of the distalmost colectomy tissue from 19 patients with inflammatory bowel disease (10 ulcerative colitis and 9 Crohn disease) and 18 patients with diverticular disease serving as controls. To determine differentially expressed miRNAs, the USeq software package identified 44 miRNAs with altered expression (fold change ≥2 and false discovery rate ≤0.10) compared with the controls. Among them, a panel of nine miRNAs was aberrantly expressed in both ulcerative colitis and Crohn disease. Validation assays performed using quantitative reverse transcription PCR (qRT-PCR) on additional frozen tissue from ulcerative colitis, Crohn disease, and control groups confirmed specific differential expression in inflammatory bowel disease for miR-31, miR-206, miR-424, and miR-146a (P<0.05). The expression of these four miRNAs was further evaluated on formalin-fixed, paraffin-embedded tissue of the distalmost colectomy mucosa from cohorts of diverticular disease controls (n=29), ulcerative colitis (n=36), Crohn disease (n=26), and the other diseases mimicking inflammatory bowel disease including infectious colitis (n=12) and chronic ischemic colitis (n=19), again confirming increased expression specific to inflammatory bowel disease (P<0.05). In summary, we demonstrate that miR-31, miR-206, miR-424, and miR-146a are novel specific biomarkers of inflammatory bowel disease. Furthermore, miR-31 is universally expressed in both ulcerative colitis and Crohn disease not only in fresh-frozen but also in formalin-fixed, paraffin-embedded tissues.",
keywords = "colon, Crohn disease, idiopathic inflammatory bowel disease, microRNA, miR-31, next-generation sequencing, ulcerative colitis",
author = "Jingmei Lin and Welker, {Noah C.} and Zijin Zhao and Yong Li and Jianjun Zhang  and Reuss, {Sarah A.} and Xinjun Zhang and Hwajeong Lee and Yunlong Liu and Bronner, {Mary P.}",
year = "2014",
doi = "10.1038/modpathol.2013.152",
language = "English",
volume = "27",
pages = "602--608",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity

AU - Lin, Jingmei

AU - Welker, Noah C.

AU - Zhao, Zijin

AU - Li, Yong

AU - Zhang , Jianjun

AU - Reuss, Sarah A.

AU - Zhang, Xinjun

AU - Lee, Hwajeong

AU - Liu, Yunlong

AU - Bronner, Mary P.

PY - 2014

Y1 - 2014

N2 - The diagnosis of idiopathic inflammatory bowel disease can be challenging. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate protein synthesis through post-transcriptioal suppression. This study is to identify new miRNA markers in inflammatory bowel disease, and to examine whether miRNA biomarkers might assist in the diagnosis of inflammatory bowel disease. Illumina small RNA sequencing was performed on non-dysplastic fresh-frozen colonic mucosa samples of the distalmost colectomy tissue from 19 patients with inflammatory bowel disease (10 ulcerative colitis and 9 Crohn disease) and 18 patients with diverticular disease serving as controls. To determine differentially expressed miRNAs, the USeq software package identified 44 miRNAs with altered expression (fold change ≥2 and false discovery rate ≤0.10) compared with the controls. Among them, a panel of nine miRNAs was aberrantly expressed in both ulcerative colitis and Crohn disease. Validation assays performed using quantitative reverse transcription PCR (qRT-PCR) on additional frozen tissue from ulcerative colitis, Crohn disease, and control groups confirmed specific differential expression in inflammatory bowel disease for miR-31, miR-206, miR-424, and miR-146a (P<0.05). The expression of these four miRNAs was further evaluated on formalin-fixed, paraffin-embedded tissue of the distalmost colectomy mucosa from cohorts of diverticular disease controls (n=29), ulcerative colitis (n=36), Crohn disease (n=26), and the other diseases mimicking inflammatory bowel disease including infectious colitis (n=12) and chronic ischemic colitis (n=19), again confirming increased expression specific to inflammatory bowel disease (P<0.05). In summary, we demonstrate that miR-31, miR-206, miR-424, and miR-146a are novel specific biomarkers of inflammatory bowel disease. Furthermore, miR-31 is universally expressed in both ulcerative colitis and Crohn disease not only in fresh-frozen but also in formalin-fixed, paraffin-embedded tissues.

AB - The diagnosis of idiopathic inflammatory bowel disease can be challenging. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate protein synthesis through post-transcriptioal suppression. This study is to identify new miRNA markers in inflammatory bowel disease, and to examine whether miRNA biomarkers might assist in the diagnosis of inflammatory bowel disease. Illumina small RNA sequencing was performed on non-dysplastic fresh-frozen colonic mucosa samples of the distalmost colectomy tissue from 19 patients with inflammatory bowel disease (10 ulcerative colitis and 9 Crohn disease) and 18 patients with diverticular disease serving as controls. To determine differentially expressed miRNAs, the USeq software package identified 44 miRNAs with altered expression (fold change ≥2 and false discovery rate ≤0.10) compared with the controls. Among them, a panel of nine miRNAs was aberrantly expressed in both ulcerative colitis and Crohn disease. Validation assays performed using quantitative reverse transcription PCR (qRT-PCR) on additional frozen tissue from ulcerative colitis, Crohn disease, and control groups confirmed specific differential expression in inflammatory bowel disease for miR-31, miR-206, miR-424, and miR-146a (P<0.05). The expression of these four miRNAs was further evaluated on formalin-fixed, paraffin-embedded tissue of the distalmost colectomy mucosa from cohorts of diverticular disease controls (n=29), ulcerative colitis (n=36), Crohn disease (n=26), and the other diseases mimicking inflammatory bowel disease including infectious colitis (n=12) and chronic ischemic colitis (n=19), again confirming increased expression specific to inflammatory bowel disease (P<0.05). In summary, we demonstrate that miR-31, miR-206, miR-424, and miR-146a are novel specific biomarkers of inflammatory bowel disease. Furthermore, miR-31 is universally expressed in both ulcerative colitis and Crohn disease not only in fresh-frozen but also in formalin-fixed, paraffin-embedded tissues.

KW - colon

KW - Crohn disease

KW - idiopathic inflammatory bowel disease

KW - microRNA

KW - miR-31

KW - next-generation sequencing

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84897546925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897546925&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2013.152

DO - 10.1038/modpathol.2013.152

M3 - Article

VL - 27

SP - 602

EP - 608

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 4

ER -